This article was written by Follow Fredrik Arnold is a retired quality service analyst sharing investment ideas with a primary focus on dividend yields...
This article was written by Follow Manika is a macroeconomist with over 20 years of experience in industries including investment management, stock broking, investment...
This article was written by Follow Leo Nelissen is an analyst focusing on major economic developments related to supply chains, infrastructure, and commodities. He...
We previously covered XPeng (NYSE:XPEV) in October 2023, discussing the market’s over-reaction to its deliveries to Israel as conflict broke out in the area,...
Banner Corporation (NASDAQ:BANR) Q1 2024 Earnings Call Transcript April 18, 2024 11:00 AM ET Company Participants Mark Grescovich – President and CEORich Arnold –...
Overview AbbVie is a research-based biopharmaceutical company with immunology, oncology, aesthetics, and neuroscience expertise. In immunology, AbbVie is known for one of the most...
It’s been two weeks since my last article, and there have been some significant developments. On the macro side, “higher for longer” rate expectations...
Investment Overview – Arvinas’s Shares Buoyant As Vepdegestrant / Ibrance Combo Study Initiated I covered the “protein degradation” specialist drug developer Arvinas (NASDAQ:ARVN) in...